Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CA1-H81E3 | Human | Biotinylated Human Catenin beta-1 Protein, His,Avitag™ (MALS verified) |
|
|
|
CA1-H51H3 | Human | Human Catenin beta-1 Protein, His Tag (MALS verified) |
|
The purity of Biotinylated Human Catenin beta-1, His,Avitag (Cat. No. CA1-H81E3) is more than 95% and the molecular weight of this protein is around 62-72 kDa verified by SEC-MALS.
The purity of Human Catenin beta-1 Protein, His Tag (Cat. No. CA1-H51H3) is more than 90% and the molecular weight of this protein is around 55-70 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CEQ-508 | CEQ-508 | Phase 2 Clinical | Marina Biotech | Adenomatous Polyposis Coli | Details |
Foscenvivint | PRI-724; ICG-001; OP-724 | Phase 2 Clinical | University Of Southern California, Prism Pharma Co Ltd | Leukemia, Myelogenous, Chronic; Liver Cirrhosis, Biliary; Solid tumours; Pancreatic Neoplasms; Liver Cirrhosis; Hepatitis B; Hepatitis C; Colorectal Neoplasms; Leukemia, Myeloid, Acute | Details |
Tegatrabetan | BC-2059; APL-121 | Phase 2 Clinical | Allergan Plc | Sarcoma, Ewing; Fibroma; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Colorectal Neoplasms; Neuroblastoma; Solid tumours; Osteosarcoma; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Wilms Tumor; Hepatoblastoma; Lymphoma, B-Cell; Fibromatosis, Aggressive; Leukemia | Details |
CWP-232291 | CWP-291; CWP-232291 | Phase 2 Clinical | Jw Pharmaceutical Corp | Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Multiple Myeloma; Primary Myelofibrosis; Leukemia, Myeloid, Acute | Details |
FOG-001 | FOG-001 | Phase 2 Clinical | Fog Pharmaceuticals Inc | Adenomatous Polyposis Coli; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
E-7386 | E-7386 | Phase 2 Clinical | Prism Pharma Co Ltd, Eisai Co Ltd | Liver Neoplasms; Solid tumours; Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Melanoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms | Details |
ALN-BCAT | ALN-BCAT | Phase 1 Clinical | Alnylam Pharmaceuticals Inc | Carcinoma, Hepatocellular | Details |
ST-316 | ST-316 | Phase 1 Clinical | Sapience Therapeutics Inc | Hematologic Neoplasms; Solid tumours; Ovarian Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Triple Negative Breast Neoplasms; Sarcoma, Synovial; Cholangiocarcinoma; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
VTX-003 | Neoplasms | Details | |||
CEQ-508 | CEQ-508 | Phase 2 Clinical | Marina Biotech | Adenomatous Polyposis Coli | Details |
Foscenvivint | PRI-724; ICG-001; OP-724 | Phase 2 Clinical | University Of Southern California, Prism Pharma Co Ltd | Leukemia, Myelogenous, Chronic; Liver Cirrhosis, Biliary; Solid tumours; Pancreatic Neoplasms; Liver Cirrhosis; Hepatitis B; Hepatitis C; Colorectal Neoplasms; Leukemia, Myeloid, Acute | Details |
Tegatrabetan | BC-2059; APL-121 | Phase 2 Clinical | Allergan Plc | Sarcoma, Ewing; Fibroma; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Colorectal Neoplasms; Neuroblastoma; Solid tumours; Osteosarcoma; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Wilms Tumor; Hepatoblastoma; Lymphoma, B-Cell; Fibromatosis, Aggressive; Leukemia | Details |
CWP-232291 | CWP-291; CWP-232291 | Phase 2 Clinical | Jw Pharmaceutical Corp | Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Multiple Myeloma; Primary Myelofibrosis; Leukemia, Myeloid, Acute | Details |
FOG-001 | FOG-001 | Phase 2 Clinical | Fog Pharmaceuticals Inc | Adenomatous Polyposis Coli; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
E-7386 | E-7386 | Phase 2 Clinical | Prism Pharma Co Ltd, Eisai Co Ltd | Liver Neoplasms; Solid tumours; Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Melanoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms | Details |
ALN-BCAT | ALN-BCAT | Phase 1 Clinical | Alnylam Pharmaceuticals Inc | Carcinoma, Hepatocellular | Details |
ST-316 | ST-316 | Phase 1 Clinical | Sapience Therapeutics Inc | Hematologic Neoplasms; Solid tumours; Ovarian Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Triple Negative Breast Neoplasms; Sarcoma, Synovial; Cholangiocarcinoma; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
VTX-003 | Neoplasms | Details |
This web search service is supported by Google Inc.